Merck scraps disappointing experimental cholesterol drug

FILE - In this Dec. 18, 2014, file photo, a person walks through a Merck company building in Kenilworth, N.J. Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results. Merck's decision Wednesday, Oct. 11, 2017, to not seek regulatory approval after years of testing marks the fourth time this type of once-promising drug has been scrapped. (AP Photo/Mel Evans, File)

TRENTON, N.J. — Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results.

Merck's decision Wednesday to not seek regulatory approval after years of testing marks the fourth time this type of once-promising drug has been scrapped. Merck had continued to study its drug, a so-called CETP inhibitor called anacetrapib, long after rivals had given up on similar drugs.

Merck raised hopes when it announced in June that anacetrapib not only lowered cholesterol, but also reduced heart attacks, deaths and other heart disease complications. But in August it disclosed the pill only cut those risks 9 percent.

That would have limited sales of the drug, if it had won regulatory approval, in part because cheap, genetic statin drugs lower cholesterol well for most people.

You may also interested in

Technology lends a hand as Spain beats France 2-0

Mar 28, 2017

Spain ended France's seven-game unbeaten run as substitutes David Silva and Gerard Deulofeu scored second-half goals to give the former world champions a 2-0 win over the European championship runner-ups at the Stade de France

US approves 3 types of genetically engineered potatoes

Mar 1, 2017

Federal officials say three types of potatoes genetically engineered to resist the pathogen that caused the Irish potato famine are safe for the environment and safe to eat

Writers say 'Peak TV' has hurt them; contract talks extended

Apr 8, 2017

So-called "Peak TV" and its expansive array of series has been great for viewers, say Hollywood scribes, but not so much for writers, and on Monday, the Writers Guild of America will resume negotiations over a new contract

People also read these

Technology lends a hand as Spain beats France 2-0

Mar 28, 2017

Spain ended France's seven-game unbeaten run as substitutes David Silva and Gerard Deulofeu scored second-half goals to give the former world champions a 2-0 win over the European championship runner-ups at the Stade de France

US approves 3 types of genetically engineered potatoes

Mar 1, 2017

Federal officials say three types of potatoes genetically engineered to resist the pathogen that caused the Irish potato famine are safe for the environment and safe to eat

Writers say 'Peak TV' has hurt them; contract talks extended

Apr 8, 2017

So-called "Peak TV" and its expansive array of series has been great for viewers, say Hollywood scribes, but not so much for writers, and on Monday, the Writers Guild of America will resume negotiations over a new contract

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH